Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin D Betthauser

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Current Opinion in Infectious Diseases|January 15, 2019
New antibiotics for community-acquired pneumoniaMarin H Kollef, Kevin D Betthauser
The Annals of Pharmacotherapy|April 5, 2021
Effect of Vasopressin Dose on Hemodynamic Response in Obese Patients With Septic Shock: A Retrospective Observational StudyCasey A Dubrawka, Kevin D Betthauser, Hannah E Pope, et al.
Open Forum Infectious Diseases|January 6, 2022
Prospective Nasal Screening for Methicillin-Resistant <i>Staphylococcus aureus</i> in Critically Ill Patients With Suspected PneumoniaNicholas Raush, Kevin D Betthauser, Karen Shen, et al.
Hospital Pharmacy|April 1, 2021
Evaluation of Amiodarone Use for New-Onset Atrial Fibrillation in Critically Ill Patients With Septic ShockKevin D Betthauser, Gabrielle A Gibson, Shannon L Piche, et al.
Current Opinion in Critical Care|August 9, 2022
New antimicrobial treatment options for severe Gram-negative infectionsLauren Hetzler, Marin H Kollef, Valerie Yuenger, et al.
Clinical Therapeutics|November 3, 2019
Outcomes of Macrolide Deescalation in Severe Community-acquired PneumoniaTiffany M Hopkins, Paul Juang, Katherine Weaver, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2021
New Perspectives on Antimicrobial Agents: Ceftolozane-TazobactamBryan D Lizza, Kevin D Betthauser, David J Ritchie, et al.
Clinical Therapeutics|November 5, 2021
Short- Versus Standard-Course Nonmacrolide Antibiotic Treatment in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Retrospective, Observational Cohort StudyKevin D Betthauser, Lindsey N Eble, Paul Juang, et al.
Pharmacotherapy|April 15, 2022
Machine learning to predict vasopressin responsiveness in patients with septic shockAileen Scheibner, Kevin D Betthauser, Alice F Bewley, et al.
Hospital Pharmacy|July 28, 2022
Impact of Stress Ulcer Prophylaxis Discontinuation Guidance in Mechanically Ventilated, Critically Ill Patients: A Pre-Post Cohort StudyChristopher A Jones, Kevin D Betthauser, Bryan D Lizza, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Opinion in Infectious Diseases|January 15, 2019
New antibiotics for community-acquired pneumoniaMarin H Kollef, Kevin D Betthauser
The Annals of Pharmacotherapy|April 5, 2021
Effect of Vasopressin Dose on Hemodynamic Response in Obese Patients With Septic Shock: A Retrospective Observational StudyCasey A Dubrawka, Kevin D Betthauser, Hannah E Pope, et al.
Open Forum Infectious Diseases|January 6, 2022
Prospective Nasal Screening for Methicillin-Resistant <i>Staphylococcus aureus</i> in Critically Ill Patients With Suspected PneumoniaNicholas Raush, Kevin D Betthauser, Karen Shen, et al.
Hospital Pharmacy|April 1, 2021
Evaluation of Amiodarone Use for New-Onset Atrial Fibrillation in Critically Ill Patients With Septic ShockKevin D Betthauser, Gabrielle A Gibson, Shannon L Piche, et al.
Current Opinion in Critical Care|August 9, 2022
New antimicrobial treatment options for severe Gram-negative infectionsLauren Hetzler, Marin H Kollef, Valerie Yuenger, et al.
Clinical Therapeutics|November 3, 2019
Outcomes of Macrolide Deescalation in Severe Community-acquired PneumoniaTiffany M Hopkins, Paul Juang, Katherine Weaver, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2021
New Perspectives on Antimicrobial Agents: Ceftolozane-TazobactamBryan D Lizza, Kevin D Betthauser, David J Ritchie, et al.
Clinical Therapeutics|November 5, 2021
Short- Versus Standard-Course Nonmacrolide Antibiotic Treatment in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Retrospective, Observational Cohort StudyKevin D Betthauser, Lindsey N Eble, Paul Juang, et al.
Pharmacotherapy|April 15, 2022
Machine learning to predict vasopressin responsiveness in patients with septic shockAileen Scheibner, Kevin D Betthauser, Alice F Bewley, et al.
Hospital Pharmacy|July 28, 2022
Impact of Stress Ulcer Prophylaxis Discontinuation Guidance in Mechanically Ventilated, Critically Ill Patients: A Pre-Post Cohort StudyChristopher A Jones, Kevin D Betthauser, Bryan D Lizza, et al.
Pageof 2